TDOC:NYE-Teladoc Inc. (USD)

EQUITY | Health Information Services | New York Stock Exchange

Last Closing

USD 9.09

Change

0.00 (0.00)%

Market Cap

USD 0.81B

Volume

3.67M

Analyst Target

USD 241.46
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Teladoc Inc provides telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-01 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

+1.19 (+1.80%)

USD 10.78B
DOCS Doximity Inc

+1.66 (+3.10%)

USD 10.37B
WEAV Weave Communications Inc

+0.26 (+1.66%)

USD 1.13B
MPLN MultiPlan Corporation

+1.26 (+9.73%)

USD 0.12B
AMWL American Well Corp

+0.44 (+6.25%)

USD 0.11B
OWLT Owlet Inc

+0.15 (+3.41%)

USD 0.08B
PHR Phreesia Inc

+1.01 (+4.01%)

N/A
FOXO FOXO Technologies Inc.

+0.02 (+6.38%)

N/A
EVH Evolent Health Inc

+0.39 (+3.39%)

N/A
VEEV Veeva Systems Inc Class A

+2.45 (+1.16%)

N/A

ETFs Containing TDOC

RWM ProShares Short Russell20.. 0.00 % 0.95 %

-0.27 (0%)

USD 0.14B
CCON 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain -57.20% 40% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -57.20% 40% F 2% F
Trailing 5 Years  
Capital Gain -89.04% 25% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -89.04% 25% F 2% F
Average Annual (5 Year Horizon)  
Capital Gain -38.21% 9% A- N/A F
Dividend Return -38.21% 9% A- N/A F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 46.65% 73% C 21% F
Risk Adjusted Return -81.90% 9% A- 2% F
Market Capitalization 0.81B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Information Services) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.